Dr Graham Hughes reflects on the importance of clinical trial sample storage.

Quality Oversight Programmes

High Standards

Third-party quality oversight programmes provide sponsors with an impartial assessment of their study, which can help to reduce costs and ensure regulatory standards are being met, as John R Wilson Jr at Beaufort, LLC discusses.

Medical Devices

Off to Market

Karen Lunde and Stephan Joeken of CERES, Clinical Evaluation & Research share their thoughts on how best to compile a clinical investigation report to gain CE approval for a medical device.

Cancer Drug Development

Data is King

Todd Clark at Value of Insight Consulting explains how the requirements of the FDA approval process can aid the development of cancer drugs by gathering information on endpoints, timelines, populations and safety results.

Clinical Trial Management

Efficient Beginnings

The development of comprehensive risk and contingency plans, as well as sound communication plans, is essential when setting up a global clinical trial, as Kellie Malloy at PharmaNet/i3 explains.

Outsourcing

The Art of Listening

Maintaining an equal and open relationship between sponsor and service provider can help ease the clinical trial process and encourage innovation, as Andy Thurstan of MD Events explores.

Electronic Document Management Systems

Know Your Numbers

Rhonda J Paz and Diandra Nuno-Salcido of GuideStar Clinical Trials Management suggest how the formation of a regulatory document can benefit from adopting the right electronic document management system.

Clinical Trial Applications

Submission Statement

Helle Ørbæk and Lillan Rejkjær of IWA Consulting explain how electroniccompatible clinical documentation provides an efficient and cost-effective method for submitting regulatory documents.

Clinical Trial Labelling

Designer Label

Global clinical trials pose considerable challenges to the labelling process. Pernille Smith of CCL Label Healthcare discusses the methods being employed to overcome these difficulties.

Phase 1 and 2a Clinical Trials

Graham Hughes reviews the key presentations on proof of concept and venture capitalism at the London conference.

Sample Management Strategy

Learn how successful sample management can help support the development of new therapies at the Global Sample Management Benchmarking Symposium.

Regional Trials: South-East Asia

SEA Power

Kenneth Lee and Helen Neal at PRA consider the growth of clinical research in South-East Asia, and suggest that understanding the unique challenges of the region is essential.

Hardware Fulfilment

Tools of the Trade

Karen Harley of Bracket and Christopher Nightingale describe how knowledge of local restrictions and regulations is critical when shipping hardware for a clinical trial, helping to prevent costly delays to the study.

Central Laboratories

Rising to the Challenge

As the clinical research sector expands and trials become increasingly complex, central laboratories must learn to adapt to new pressures, as Graham Hughes and Richard Barrett, Consultants in Pharmaceutical Development discuss.

Metrics Champion Consortium

From Evolution to Revolution

Guy A Mascaro of the Metrics Champion Consortium explains the role that the organisation is playing in helping sponsors to improve the clinical research process.

Adaptive Designs: Early Phase Trials

Keys to Successful Design

Denis Gossen and Dominique Demolle of Aepodia explain how, with adequate planning, adaptive trial designs in early phase research can help to improve accuracy and efficiency.

Post-Marketing Research

Planting the Seed

Post-marketing research (PMR) is growing in importance, with regulatory authorities increasingly requiring studies that confirm the ongoing safety of a newly-approved drug. Thomas Wagner of Trilogy Writing & Consulting advises on how to design a successful PMR plan.

Patient-Friendly Trials

Home is Where the Trial is

Home trials can be difficult to set up, but Graham Wylie of the Medical Research Network suggests that these studies are worth the risk as they offer considerable benefits to patient recruitment and retention.

Industry Interview

Thinking Allowed

ICT talks to Steve Cutler of ICON Clinical Research Services about his views on the clinical trials industry and how it might develop in the future.